• FirefoxUpgrade to the new Firefox »
  •  Dow Down0.79% Nasdaq Up0.16%

    More On ONC.TO

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    Oncolytics Biotech Inc. (ONC.TO)

    -Toronto
    0.57 0.00(0.00%) Jan 23, 3:22PM EST
    Add to Portfolio
    ProfileGet Profile for:
    Oncolytics Biotech Inc.
    1167 Kensington Crescent NW
    Suite 210
    Calgary, AB T2N 1X7
    Canada - Map
    Phone: 403-670-7377
    Fax: 403-283-0858
    Website: http://www.oncolyticsbiotech.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Biotechnology
    Full Time Employees:N/A

    Business Summary 

    Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancers. The company develops REOLYSIN, a therapeutic reovirus that is in various clinical trials for use as human cancer therapeutic. Its cancer product is a potential therapeutic for tumours possessing an activated Ras pathway. The company was founded in 1998 and is headquartered in Calgary, Canada.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Oncolytics Biotech Inc.

    Key Executives 
     PayExercised
    Dr. Bradley G. Thompson Ph.D.,
    Exec. Chairman, Chief Exec. Officer and Pres
    810.00K0.00
    Mr. Kirk J. Look CA,
    Chief Financial Officer, Principal Accounting Officer and Chief Financial Officer of Oncolytics Biotech (U.S.) Inc.
    411.00K0.00
    Dr. Matthew C. Coffey Ph.D.,
    Chief Operating Officer and Director
    529.00K0.00
    Dr. George M. Gill M.D.,
    Chief Safety Officer and Sr. VP of Clinical & Regulatory Affairs
    458.00K0.00
    Dr. Alan J. Tuchman M.D., MBA, (FANN), 68
    Chief Medical Officer and Sr. VP of Medical & Clinical Affairs
    207.00K0.00
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in CAD.